Opioids for dyspnoea in interstitial lung disease: does the sequence and timing of therapy matter?

Eur Respir J. 2024 Jul 11;64(1):2301956. doi: 10.1183/13993003.01956-2023. Print 2024 Jul.

Meena Kalluri^{1

2}, Subhabrata Moitra^{3

4}, Janice Richman-Eisenstat^{3

2}, Giovanni Ferrara^{3

2}, Elisabeth Bendstrup^{5

6}, Kristoffer Marsaa⁷

¹ Division of Pulmonary Medicine, University of Alberta, Edmonton, AB, Canada [email protected].
² Alberta Health Services, Edmonton Zone, Edmonton, AB, Canada.
³ Division of Pulmonary Medicine, University of Alberta, Edmonton, AB, Canada.
⁴ Canadian VIGOUR Centre, University of Alberta, Edmonton, AB, Canada.
⁵ Center for Rare Lung Diseases, Department of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Denmark.
⁶ Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
⁷ Department of Multimorbidity, North Zealand Hospital, Hilleroed, Copenhagen University, Hilleroed, Denmark.

No abstract available

Publication types